Publish Date
7.0% of adults aged 65 years reported past-month cannabis use in 2023 vs 4.8% in 2021.
HealthDay News — From 2021 to 2023, the prevalence of current cannabis use increased among older U.S. adults, according to a research letter published online June 2 in JAMA Internal Medicine.
Benjamin H. Han, M.D., from the University of California, San Diego, and colleagues estimated recent changes in current cannabis use among U.S. adults aged 65 years and older, as well as emerging sociodemographic and clinical characteristics in this population. The analysis included data from 15,689 older adults participating in the National Survey on Drug Use and Health (2021 to 2023).
The researchers found that prevalence of past-month cannabis use among older adults increased significantly from 4.8 percent in 2021 to 7.0 percent in 2023. Increased past-month cannabis use prevalence was associated with older adults identifying as other race (1.6 percent in 2021; 7.4 percent in 2023), as well as among women, White individuals, those with a college or postgraduate degree, individuals with an annual income of ≥$75,000, married people, and those living in a state with legalized medical cannabis. An increased prevalence in past-month cannabis use was also associated with several clinical conditions, notably chronic obstructive pulmonary disease (6.4 to 13.5 percent), as well as heart conditions, diabetes, hypertension, cancer, and two or more chronic medical conditions.
“As a geriatrician, I see more and more people interested in using cannabis for treating chronic health symptoms. But cannabis can complicate the management of chronic diseases and be potentially harmful if patients are not educated on its use and potential risks,” Han said in a statement.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Loading…
Loading…
Enjoying our content?
Thanks for visiting Pulmonology Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Pulmonology Advisor. Register for free and gain unlimited access to:
– Clinical News, with personalized daily picks for you
– Case Studies
– Conference Coverage
– Full-Length Features
– Drug Monographs
– And More
{{login-button}} {{register-button}}
Loading…
Loading…
Want to read more?
Please login or register first to view this content.

0 Comments